A COVID-19 vaccine in early November? ‘Extremely unlikely, but not impossible’: Warp Speed head Slaoui esagonowsky Fri, 09/04/2020 […]

With new AveXis name, Novartis spotlights marquee role for gene therapy business bbulik Fri, 09/04/2020 – 09:19

FiercePharmaAsia—Biocon, Mylan’s Lantus copy; Samsung rides COVID demand; Adlai Nortye’s C round aliu Fri, 09/04/2020 – 06:28

The Ellipsys Vascular Access System reduces the time before patients with kidney failure can start lifesaving dialysis treatments, […]

An increased awareness on a molecular level of what mechanisms prostate cancer cells use to become mobile and […]

The medicine is being assessed for treating adults hospitalised with the virus

The findings have validated confidence in the experimental vaccine, the firm noted

The technique has been used to generate a high-affinity antibody against Arginase 2, an enzyme implicated in major […]

Four papers have been published reinforcing evidence that steroids can significantly improve the outcomes for those critically ill […]

Updated Date: Thu, 27 Aug 2020 00:00:00 EDT